HIV 1 News and Research

RSS

Researchers make significant progress in developing frontline protection against HIV infection

Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.

22 Nov 2016

Scientists uncover novel process by which APOL1 gene contributes to renal disease

A Children's National Health System research team has uncovered a novel process by which the gene APOL1 contributes to renal disease, according to a paper published November 18 in the Journal of the American Society of Nephrology.

18 Nov 2016

Scientists develop genetically engineered T cells with fusion inhibitor to disrupt HIV's harpoon

When HIV attacks a T cell, it attaches itself to the cell's surface and launches a "harpoon" to create an opening to enter and infect the cells.

18 Nov 2016

Scientists develop new model to help eliminate HIV vulnerability among racial/ethnic groups

Although HIV rates are higher among the African American community compared to the White population, research shows that engagement in risky behaviors does not fully account for these differences.

17 Nov 2016

Suppressed vaginal immune response makes women more susceptible to RNA viruses

Scientists at the Gladstone Institutes discovered that the vaginal immune system is suppressed in response to RNA viruses, such as Zika.

16 Nov 2016

GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

George Washington University researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.

16 Nov 2016

Study: Fungal asthma in UK greatly exceeds prior estimates

Experts are warning of a significant increase in the number of people in the UK who are living with invasive and serious fungal diseases that affect the lungs, bloodstream and brain and can sometimes lead to death.

16 Nov 2016

D.C. Council passes ‘Death with Dignity Act’ by a veto-proof 11-2 margin

Compassion & Choices reports the District of Columbia is poised to become the seventh jurisdiction in the U.S. where medical aid in dying is authorized for terminally ill residents after the D.C. Council passed the D.C. Death with Dignity Act by a veto-proof 11-2 margin.

16 Nov 2016

Research findings suggest efficacy of conventional flu vaccines can be improved

A team of engineers and scientists at The University of Texas at Austin is reporting new findings on how the influenza vaccine produces antibodies that protect against disease, research that suggests that the conventional flu vaccine can be improved.

15 Nov 2016

NIH researchers identify antibody that potently neutralizes 98% of HIV strains

Scientists from the National Institutes of Health have identified an antibody from an HIV-infected person that potently neutralized 98 percent of HIV isolates tested, including 16 of 20 strains resistant to other antibodies of the same class.

15 Nov 2016

CannaCure Florida offers medical cannabis educational conference following legalization of marijuana

CannaCure Florida is proudly offering the most comprehensive medical cannabis educational conference following passage of Florida Amendment 2 legalizing medical marijuana.

14 Nov 2016

Prevalence of HIV in western Nepal linked to lack of technical and vocational education

Human Immunodeficiency Virus (HIV) is a global health problem, especially affecting developing countries due to lack of education and awareness of the possible means of transmission.

11 Nov 2016

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy

10 Nov 2016

New technology uses USB stick to monitor HIV in bloodstream

The device, created by scientists at Imperial College London and DNA Electronics, uses a drop of blood to detect HIV, and then creates an electrical signal that can be read by a computer, laptop or handheld device.

10 Nov 2016

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

The administration of VRC01, a potent and broadly neutralizing HIV-specific antibody, is safe, is well-tolerated, generated high plasma concentrations and modestly delayed the return of HIV viral rebound in HIV-1 infected individuals after they stopped receiving antiretroviral therapy, according to a study published in the New England Journal of Medicine by researchers at the University of Alabama at Birmingham, the National Institutes of Health and the University of Pennsylvania Penn Center for AIDS Research.

10 Nov 2016

MedUni Vienna creates physical training programme to reactivate older adults

According to recent studies, around 11% of people aged over 65 are "frail", and 41% are on their way to becoming so.

10 Nov 2016

Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Immunotherapy has revolutionized treatment options in oncology, neurology, and many infectious diseases and now there is fresh hope that the same method could be used to treat or functionally cure HIV, according to two related studies from Perelman School of Medicine at the University of Pennsylvania, the University of Alabama at Birmingham, and the National Institutes of Health.

9 Nov 2016

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

A study led by researchers at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research, Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV.

9 Nov 2016

Investigational treatment combination improves virologic control in SIV-infected monkeys

Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.

9 Nov 2016

First month after infection is key period to control drug-related HIV spread, research reveals

Data from the mid-1990s AIDS epidemic in Russia and Ukraine shows that the first month after infection is the key period to control the spread of the virus in drug-using populations, according to a new study by researchers at Oxford University.

9 Nov 2016

HIV 1 News and Research

Researchers make significant progress in developing frontline protection against HIV infection

Scientists uncover novel process by which APOL1 gene contributes to renal disease

Scientists develop genetically engineered T cells with fusion inhibitor to disrupt HIV's harpoon

Scientists develop new model to help eliminate HIV vulnerability among racial/ethnic groups

Suppressed vaginal immune response makes women more susceptible to RNA viruses

GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

Study: Fungal asthma in UK greatly exceeds prior estimates

D.C. Council passes ‘Death with Dignity Act’ by a veto-proof 11-2 margin

Research findings suggest efficacy of conventional flu vaccines can be improved

NIH researchers identify antibody that potently neutralizes 98% of HIV strains

CannaCure Florida offers medical cannabis educational conference following legalization of marijuana

Prevalence of HIV in western Nepal linked to lack of technical and vocational education

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

New technology uses USB stick to monitor HIV in bloodstream

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

MedUni Vienna creates physical training programme to reactivate older adults

Research offers new insights into how immunotherapy could help treat or functionally cure HIV

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Investigational treatment combination improves virologic control in SIV-infected monkeys

First month after infection is key period to control drug-related HIV spread, research reveals

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News